OcuCure Therapeutics is Pharmaceuticals in United States that focus on diabetic retinopathy diseases business. Founded in 2005. They cover business area such as developer, topical eye drop, age-relate macular degeneration, diabetic retinopathy disease, clinically significant concentration, any toxic effect, patient, vision loss, eye disease.
2005
( 19 years old in 2024 )
Diabetic Retinopathy Diseases
-
15 East Salem Avenue
Suite 201
Roanoke, VA 24011
United States
Private
developertopical eye dropage-relate macular degenerationdiabetic retinopathy diseaseclinically significant concentrationany toxic effectpatientvision losseye disease
* We use standard office opening hours in near OcuCure Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
OcuCure Therapeutics is Pharmaceuticals business from United States that founded in 2005 (19 years old in 2024), OcuCure Therapeutics business is focusing on Diabetic Retinopathy Diseases.
OcuCure Therapeutics headquarter office and corporate office address is located in 15 East Salem Avenue Suite 201 Roanoke, VA 24011 United States.
OcuCure Therapeutics was founded in United States.
In 2024, OcuCure Therapeutics is currently focus on diabetic retinopathy diseases sector.
Above is snippet of Google Trends for "diabetic retinopathy diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with OcuCure Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
